|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 249.80 EUR | -0.16% |
|
+2.67% | +4.69% |
| Jul. 14 | Where would AI lead Pharma in the long run? | ![]() |
| Jul. 13 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| Market Cap | 47.63B 54.27B 44.35B 40.79B 76.47B 5,185B 77.78B 526B 206B 2,571B 204B 199B 8,884B | P/E 2026 * |
26.8x | P/E 2027 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 47.39B 54B 44.13B 40.59B 76.08B 5,159B 77.39B 524B 205B 2,558B 203B 198B 8,839B | EV / Sales 2026 * |
5.55x | EV / Sales 2027 * | 4.7x |
| Free-Float |
61.59% | Yield 2026 * |
0.59% | Yield 2027 * | 0.6% |
Last Transcript: UCB
| 1 day | -0.08% | ||
| 1 week | +2.75% | ||
| Current month | -4.58% | ||
| 1 month | -5.12% | ||
| 3 months | +10.52% | ||
| 6 months | -1.19% | ||
| Current year | +4.78% |
| 1 week | 238.9 | 251.3 | |
| 1 month | 230.7 | 268.3 | |
| Current year | 223 | 289.5 | |
| 1 year | 181.15 | 289.5 | |
| 3 years | 65.4 | 289.5 | |
| 5 years | 65.4 | 289.5 | |
| 10 years | 54.84 | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Buy | Director | 500 | 0.0003% | ||
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.04% | +2.75% | +35.10% | +210.48% | 54.27B | ||
| +4.20% | +2.96% | +24.44% | -6.82% | 70.73B | ||
| +0.26% | +54.90% | +54.90% | +54.90% | 49.28B | ||
| +7.15% | +8.59% | -52.92% | -52.31% | 39.94B | ||
| +2.73% | +1.21% | +59.04% | -22.48% | 30.36B | ||
| +9.30% | +10.68% | +85.19% | +105.94% | 25.96B | ||
| +0.31% | -6.46% | +64.57% | -52.97% | 22.14B | ||
| -0.22% | -2.76% | -10.26% | +159.25% | 19.96B | ||
| +1.70% | +3.76% | +85.05% | +148.55% | 16.77B | ||
| +0.96% | +1.55% | +66.45% | +128.35% | 16.72B | ||
| Average | +2.64% | +2.40% | +41.16% | +67.29% | 34.61B | |
| Weighted average by Cap. | +2.78% | +3.22% | +34.65% | +58.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.54B 9.73B 7.96B 7.32B 13.72B 930B 13.95B 94.38B 36.94B 461B 36.55B 35.76B 1,594B | 9.64B 10.99B 8.98B 8.26B 15.48B 1,050B 15.75B 107B 41.7B 521B 41.25B 40.36B 1,799B |
| Net income | 1.77B 2.02B 1.65B 1.52B 2.84B 193B 2.89B 19.55B 7.65B 95.56B 7.57B 7.41B 330B | 2.28B 2.59B 2.12B 1.95B 3.66B 248B 3.72B 25.16B 9.85B 123B 9.74B 9.53B 425B |
| Net Debt | -242M -276M -226M -207M -389M -26.37B -396M -2.68B -1.05B -13.08B -1.04B -1.01B -45.18B | -2.32B -2.65B -2.16B -1.99B -3.73B -253B -3.79B -25.67B -10.05B -125B -9.94B -9.72B -433B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | €249.80 | -0.16% | 19,829 |
| 26-07-28 | €250.20 | +1.79% | 227,096 |
| 26-07-27 | €245.80 | -0.08% | 136,709 |
| 26-07-24 | €246.00 | +1.23% | 149,516 |
| 26-07-23 | €243.00 | -0.12% | 205,984 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions




















